tiprankstipranks
Advertisement
Advertisement

CLLS Stock Latest News

Cellectis initiated with an Overweight at Barclays
The FlyCellectis initiated with an Overweight at Barclays
7d ago
CLLS
Cellectis Calls June 25, 2026 Shareholders’ Meeting to Approve 2025 Results and Broad Capital-Issuance Powers
PremiumCompany Announcements
Cellectis Calls June 25, 2026 Shareholders’ Meeting to Approve 2025 Results and Broad Capital-Issuance Powers
14d ago
6K
CLLS
Cellectis Sets June 25, 2026 Date for Annual Shareholders Meeting in Paris
PremiumCompany Announcements
Cellectis Sets June 25, 2026 Date for Annual Shareholders Meeting in Paris
15d ago
6K
CLLS
Cellectis to present clinical data on lasme-cel, eti-cel at EHA Congress
PremiumThe Fly
Cellectis to present clinical data on lasme-cel, eti-cel at EHA Congress
23d ago
CLLS
Cellectis to Unveil Key Lasme-cel and Eti-cel Data at EHA 2026
PremiumCompany Announcements
Cellectis to Unveil Key Lasme-cel and Eti-cel Data at EHA 2026
23d ago
6K
CLLS
Cellectis reports Q1 adjusted EPS (16c) vs. (17c) last year
PremiumThe FlyCellectis reports Q1 adjusted EPS (16c) vs. (17c) last year
24d ago
CLLS
Cellectis sees cash runway into 4Q27
Premium
The Fly
Cellectis sees cash runway into 4Q27
24d ago
CLLS
Cellectis Files Q1 2026 Interim Financials with U.S. SEC
Premium
Company Announcements
Cellectis Files Q1 2026 Interim Financials with U.S. SEC
24d ago
6K
CLLS
Cellectis Q1 2026 Results Highlight CAR-T Pipeline Milestones, New Epigenetic Platform and Licensing Dispute
PremiumCompany Announcements
Cellectis Q1 2026 Results Highlight CAR-T Pipeline Milestones, New Epigenetic Platform and Licensing Dispute
24d ago
6K
CLLS
CLLS Earnings this Week: How Will it Perform?
PremiumPre-Earnings
CLLS Earnings this Week: How Will it Perform?
26d ago
CLLS
Cellectis to Release First-Quarter 2026 Results on May 11
PremiumCompany Announcements
Cellectis to Release First-Quarter 2026 Results on May 11
1M ago
6K
CLLS
Cellectis Showcases Safer Epigenetic Gene-Silencing Platform Ahead of ASGCT 2026
PremiumCompany Announcements
Cellectis Showcases Safer Epigenetic Gene-Silencing Platform Ahead of ASGCT 2026
1M ago
6K
CLLS
Cellectis Highlights Positive Pivotal Interim Data for Allogeneic CAR-T Partnered Cema-cel
PremiumCompany AnnouncementsCellectis Highlights Positive Pivotal Interim Data for Allogeneic CAR-T Partnered Cema-cel
2M ago
6K
CLLS
Cellectis highlights Allogene ALPHA3 trial data, potential milestone payments
Premium
The Fly
Cellectis highlights Allogene ALPHA3 trial data, potential milestone payments
2M ago
ALLO
CLLS
Cellectis Posts 2025 Results, Highlights Strong Allogeneic CAR-T Data and Cash Runway Into 2027
Premium
Company Announcements
Cellectis Posts 2025 Results, Highlights Strong Allogeneic CAR-T Data and Cash Runway Into 2027
3M ago
6K
CLLS
Cellectis S.A. Sets March 19 Release Date for Q4 and Full-Year 2025 Results
PremiumCompany Announcements
Cellectis S.A. Sets March 19 Release Date for Q4 and Full-Year 2025 Results
3M ago
6K
CLLS
CLLS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
CLLS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
CLLS
Cellectis Sets 2026 Clinical Milestones and Extends Cash Runway Into H2 2027
PremiumCompany Announcements
Cellectis Sets 2026 Clinical Milestones and Extends Cash Runway Into H2 2027
5M ago
6K
CLLS
Cellectis initiated with a Buy at Clear Street
PremiumThe Fly
Cellectis initiated with a Buy at Clear Street
5M ago
CLLS
Cellectis Announces Arbitral Decision in Servier Dispute
PremiumCompany AnnouncementsCellectis Announces Arbitral Decision in Servier Dispute
6M ago
6K
CLLS
Allogene Therapeutics says favorable result for Servier in Cellectis arbitration
Premium
The Fly
Allogene Therapeutics says favorable result for Servier in Cellectis arbitration
6M ago
ALLO
CLLS
Cellectis announces arbitral decision in dispute with Servier
Premium
The Fly
Cellectis announces arbitral decision in dispute with Servier
6M ago
CLLS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >